Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease-Reference-Cited by-同舟云学术

Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease

Published:1999-10-12 Issue:21 Volume:96 Page:12120-12125
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Corti O.,Sanchez-Capelo A.,Colin P.,Hanoun N.,Hamon M.,Mallet J.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference44 articles.

1. "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY

2. In VivoAdenovirus-Mediated Gene Transfer for Parkinson's Disease

3. Application ofex VivoGene Therapy in the Treatment of Parkinson's Disease

4. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinsonʼs disease

5. Long-Term Behavioral Recovery in Parkinsonian Rats by an HSV Vector Expressing Tyrosine Hydroxylase

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders;Advances in Neurobiology;2023

2. Pharmacological approach using doxycycline and tocopherol in rotenone induced oxidative stress, neuroinflammation and Parkinson’s like symptoms;International Journal of Neuroscience;2022-12-16

3. Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice;Drug Delivery;2017-01-01

4. Regulated Gene Therapy;Gene Therapy for Neurological Disorders;2016

5. Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's Disease;Molecular Therapy;2015-05